Alcohol & Drug Abuse Programs and 12 more...less...

Vermont Department of Health - AHS Goal 2

Substance Use Disorder Treatment Services

Alcohol & Drug Abuse Programs (PPMB)

Vermont Department of Health - Alcohol & Drug Abuse Programs - Opioids

AHS performance measures


ADAP Opioids

ADAP Act 186

ADAP AHS Strategic Plan


Increase access to substance use disorder services. AHS will increase access to effective substance use disorder services for families and individuals to mitigate the impact of substance use disorders in Vermont communities.

Substance Abuse Treatment

Access to MAT: Are adults seeking help for opioid addiction receiving treatment? Measured as the number of people receiving Medication Assisted Treatment per 10,000 Vermonters age 18-64.

244Q4 2021

Line Bar
Story Behind the Curve

Last Reviewed: August 2021. Author: Alcohol & Drug Abuse Programs, Vermont Department of Health

The use of heroin and misuse of other opioids (e.g., prescription narcotics) has been identified as a major public health challenge in Vermont. The potential health, social, and economic consequences of this problem have led to the development of a comprehensive treatment system that is focused on opioid addiction. This system, known as the Hub and Spokes, has significantly increased access to care, including medication assisted treatment, Vermont.

Vermont has a multifaceted approach to addressing opioid use disorder that involves multiple community partners. Programs and services include regional prevention efforts, drug take back programs, intervention services through the monitoring of opioid prescriptions with the Vermont Prescription Monitoring System (VPMS), recovery services at eleven Recovery Centers, overdose death prevention through the distribution of Naloxone rescue kits, and a full array of treatment modalities of varying intensities to fit individual needs. Vermont is also working with communities on initiatives, including Rapid Access to Medication Assisted Treatment (RAM) and Recovery Coaching in Emergency Departments to both increase ways people with opioid use disorders can get into treatment and to support them in staying in treatment.

For those with opioid dependence, treatment with methadone or buprenorphine, medications used to reduce cravings for opioids (e.g., heroin, prescription pain relievers, etc.), can allow individuals the opportunity to lead normal lives. Medication assisted treatment (MAT) was originally developed because detoxification followed by abstinence-oriented treatment was not very effective in preventing a return to opioid use. People who use opioids after detoxing are at high risk over overdose. There is clear evidence that medication assisted treatment using either methadone or buprenorphine helps reduce the risk of overdose deaths and can increase the likelihood that people will stay in treatment and achieve recovery. The positive effects of medication assisted treatment can include: abstinence or reduced use of opioids; reduction in non-opioid drug use (e.g., cocaine); decreased criminal behavior; and decreased risk behavior linked to HIV and hepatitis C infections.

NOTE:  Number for Q3 2019 and forward are estimates due to late reporting by some Hub locations.  Numbers will be retroactively updated as new information is available.

  • Individuals receiving treatment and their families
  • Community Providers-such as Licensed Alcohol & Drug Counselors (LADCs), primary care physicians and mental health practitioners
  • ADAP Preferred Providers
  • Spoke facilities providing medication assisted treatment for those with opioid use disorders
  • Recovery Centers
  • AHS Departments (Department of Vermont Health Access, Vermont Department of Health-Division of Alcohol and Drug Abuse Programs, Department for Children and Families, Department of Corrections, Department of Aging and Independent Living, Department of Mental Health)
What Works

Medication assisted treatment is an effective evidence-based treatment for opioid addiction.

Action Plan

The primary focus of the Hub and Spoke system has been to expand access to care for individuals with opioid use disorders. The number of people receiving MAT services has continued to increase statewide.

Why Is This Important?

Together these performance measures focus on whether Vermonters are better off as a result of Health Department's Alcohol & Drug Abuse Program. They do so by looking at the quality and efficiency of these programs and services. This performance measure is important because it measures HOW MUCH the program is doing; it measures quantity of program effort.

Notes on Methodology

Numbers are based on the number of people receiving medication assisted treatment in hubs and spokes during the first month of the quarter as to minimize churn and not over represent the number of people receiving care.  Please note that numbers are subject to change due to lags in receipt of data and the most recent four measures should be considered estimates.

The numerator is the number of hub and spoke clients receiving services in a month

Hub client – an individual receiving a MAT service that is reported in the Substance Abuse Treatment Information System (SATIS) dataset. This includes all payers.

Spoke client – an individual receiving a prescription for buprenorphine during the month.  The data source is the Vermont Prescription Monitoring System (VPMS) which includes all scheduled II-IV drugs dispensed by Vermont Licensed Pharmacies.  Please note that it does not include prescriptions filled by Vermonters in other states which means that the actual number may be somewhat higher.  It also excludes any prescription filled in Vermont by a person who does not live in Vermont.  

The denominator is the number of Vermonters aged 18-64 (based on Vermont Health Department and Census estimates) divided by 10,000.

Scorecard Result Container Indicator Measure Action Actual Value Target Value Tag S R I P PM A m/d/yy m/d/yyyy